Literature DB >> 16616156

Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors.

Carlos Gonzalez-Juanatey1, Encarnacion Amigo-Diaz, Jose A Miranda-Filloy, Ana Testa, Javier Revuelta, Carlos Garcia-Porrua, Javier Martin, Javier Llorca, Miguel A Gonzalez-Gay.   

Abstract

OBJECTIVE: To assess the prevalence of echocardiographic and Doppler abnormalities in psoriatic arthritis (PsA) patients without clinically evident cardiovascular manifestations or classic atherosclerosis risk factors.
METHODS: Fifty PsA patients were recruited from Hospital Xeral-Calde, Lugo, Spain. Patients seen during the period of recruitment that had classic cardiovascular risk factors or had suffered cardiovascular or cerebrovascular events were excluded. Fifty healthy matched controls were also studied. Echocardiographic and Doppler studies were performed in all cases and controls.
RESULTS: In PsA patients the frequency of aortic and tricuspid (10%) and mitral regurgitation (16%) was not different from that seen in matched controls (10, 4, and 12%). Also, the pulmonary artery systolic pressure was normal in the group of PsA patients (23.4+/-3.9 mm Hg). The prevalence of diastolic dysfunction, in all cases due to impaired relaxation, was similar in PsA patients (28%) and controls (24%) (P=0.65). In addition, no significant echocardiographic and Doppler differences were observed when PsA patients with polyarticular pattern were compared with the remaining PsA patients.
CONCLUSIONS: The present study shows that actively treated PsA patients without cardiovascular risk factors or clinically evident cardiovascular disease do not exhibit silent subclinical echocardiographic abnormalities.

Entities:  

Mesh:

Year:  2006        PMID: 16616156     DOI: 10.1016/j.semarthrit.2005.12.002

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  9 in total

1.  The burden of psoriatic arthritis: a literature review from a global health systems perspective.

Authors:  Seina Lee; Alan Mendelsohn; Evelyn Sarnes
Journal:  P T       Date:  2010-12

Review 2.  The perspective on psoriatic arthritis in Asia.

Authors:  Ying-Ying Leung; Lai-Shan Tam; Edmund K Li
Journal:  Curr Rheumatol Rep       Date:  2011-08       Impact factor: 4.592

Review 3.  Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature.

Authors:  Rita V Patel; Michael L Shelling; Srdjan Prodanovich; Daniel G Federman; Robert S Kirsner
Journal:  J Gen Intern Med       Date:  2011-04-07       Impact factor: 5.128

4.  Extra-articular manifestations in psoriatic arthritis patients.

Authors:  Rosario Peluso; Salvatore Iervolino; Maria Vitiello; Vincenzo Bruner; Gelsy Lupoli; Matteo Nicola Dario Di Minno
Journal:  Clin Rheumatol       Date:  2014-05-08       Impact factor: 2.980

Review 5.  Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.

Authors:  Santos Castañeda; Carlos González-Juanatey; Miguel A González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

Review 6.  National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

Authors:  Alexa B Kimball; Dafna Gladman; Joel M Gelfand; Kenneth Gordon; Elizabeth J Horn; Neil J Korman; Gretchen Korver; Gerald G Krueger; Bruce E Strober; Mark G Lebwohl
Journal:  J Am Acad Dermatol       Date:  2008-03-04       Impact factor: 11.527

7.  Cardiovascular risk in patients with psoriatic arthritis.

Authors:  Tracy Y Zhu; Edmund K Li; Lai-Shan Tam
Journal:  Int J Rheumatol       Date:  2012-05-08

8.  Influence of psoriasis on circulatory system function assessed in echocardiography.

Authors:  Sylwia Milaniuk; Aldona Pietrzak; Barbara Mosiewicz; Jerzy Mosiewicz; Kristian Reich
Journal:  Arch Dermatol Res       Date:  2015-06-28       Impact factor: 3.017

9.  Cardiac manifestations of rheumatological conditions: a narrative review.

Authors:  Mohammad Bagher Owlia; Seyed Mohammad Yousof Mostafavi Pour Manshadi; Nafiseh Naderi
Journal:  ISRN Rheumatol       Date:  2012-10-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.